Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: This is an updated component network meta-analysis to evaluate efficacy and safety of va...
Cancer remains a major global health challenge, and the increasing availability of multimodal biomed...
BACKGROUND: Lung cancer remains one of the leading causes of cancer-related mortality worldwide. Cur...
BACKGROUND: This study aimed to develop an integrated artificial intelligence (AI) pipeline for cerv...
BACKGROUND: Bladder cancer (BC) remains a prevalent malignancy with a high recurrence rate; however,...
Outer membrane vesicles (OMVs), naturally released by Gram-negative bacteria, represent a unique cla...
BACKGROUND: Circulating tumor DNA (ctDNA) detection offers minimally invasive monitoring of cancer f...
Cell-in-cell (CIC) structures are among the most intriguing cellular phenomena occasionally observed...
BACKGROUND: Artificial intelligence (AI) applied to magnetic resonance imaging (MRI) may improve det...
Growing concerns regarding per- and polyfluoroalkyl substances (PFAS) as pervasive environmental con...
BACKGROUND: Lysosomes are essential for intracellular degradation and recycling, and changes in thei...
Esophageal cancer (EC) is a gastrointestinal malignancy associated with a poor prognosis worldwide. ...
OBJECTIVE: To investigate the potential of magnetic resonance imaging (MRI) radiomics-based machine ...
PURPOSE: With trastuzumab deruxtecan demonstrating clinical benefit in HER2-low and ultralow breast ...
Early and accurate diagnosis remains a major challenge in cervical cancer management. This study aim...
Despite substantial advances in radiotherapy and chemotherapy for nasopharyngeal carcinoma (NPC), a ...
Precise cancer lesion analysis in medical imaging critically depends on the accurate definition of r...
Metabolic reprogramming is a core hallmark of cancer, yet how it contributes to the clinical heterog...
Marginal zone lymphoma (MZL) is an indolent B-cell non-Hodgkin lymphoma with marked heterogeneity. C...
BACKGROUND: We compared performance across 3 breast cancer risk domains-clinical, polygenic, and mam...
INTRODUCTION: OSAS is a common yet underdiagnosed condition, particularly among patients with head a...